The global influenza
vaccine market is growing significantly due increasing awareness about the
pandemic influenza viruses and increasing government involvement for
vaccination against influenza viruses.Massive unexplored influenza vaccine
marketin the emerging economiesare creating ample opportunities for the global
influenza vaccine marketto grow at a significant rate in the forecasted
period.The advanced research and development facilities and new vaccine
developments by the companies are propelling the demand for safe and
efficacious influenza vaccine. Influenza (flu) is a respiratory disease caused
by mainly two types of influenza viruses namely, influenza A and B viruses.
Influenza A viruses are of two types based on the proteins on the surface of
virus: hemagglutinin (H) and neuraminidase (N).
In global
influenza vaccine industry, there is a trend of development of intranasal
vaccine due to the ease of self administration. According to Centers for
Disease Control and Prevention (CDC),in 2009, approximately 151,700 to 575,400
people died due to H1N1 influenza pandemic or swine flu across the globe. In
addition, the organization also reported that most deaths due to 2009 flu
pandemic occurred in Africa and Southeast Asia region. Several vaccines have
been developed to prevent pandemic and seasonal influenza viruses using
recombinant DNA technology and extensive researches are going on to develop
efficient influenza vaccines using cell culture technology. Various
governmental and non-governmental organizations have been actively involved in
promoting and monitoring vaccination programs aimed at immunising people
against seasonal influenza viruses. This in turn fuels the growth of global
influenza vaccine market.
Request to Get the
Sample Pages at:
Some of the
factors driving the growth of the global influenza vaccine market are
increasing research and development activities,increasing investment by
companies for the development of influenza vaccine, technological advancements
in recombinant DNA technology, large number of population with no immunization
against influenza viruses in emerging economies,increasing healthcare
expenditure, and increasing involvement of government and non-government
organizations.In addition, geriatric population and people suffering from
chronic diseases are at higher risk of developing influenza virus infection;
hence, aging population and increasing prevalence of chronic diseases are also
driving the demand of influenza vaccine market. However, stringent regulatory
framework and low accessibility to remote areas aresome of the factors
restraining the growth of the global influenza vaccine market to some extent.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=influenza-vaccine-market
Geographically,
North America will be leading the global influenza vaccine market in the coming
years, due to high awareness of influenza viruses, high healthcare expenditure,
and increasing research and development activities.In addition, the U.S. Food
and Drug Administration (FDA), recommends vaccination as the most effective
method to prevent influenza; hence, fueling the growth of influenza vaccine
market in NorthAmerica region. Asia-Pacificis the fastest growing region in the
global influenza vaccinemarket. The major reasons for the fastest growth in the
region are massive unexplored market (as large number of people donot have
access to vaccination), increasing involvement of government, and increasing
healthcare expenditure.
Some of the
major players operating in the global
influenza vaccine market are GlaxoSmithKline,Sanofi Pasteur, Inc., ID
Biomedical Corporation, CSL Limited, Novartis, Protein Sciences Corporaton,
MedImmune, LLC, Sinovac Biotech, Serum Institute of India, and Hualun
Biologicalsamong others.
